Wednesday, March 27, 2019

2019 Becoming a Big Year for Mergers, Acquisitions and Expansion in #Cannabis; (NYSE: $CGC) (OTC: $SING) (OTC: $HRVSF) (CSE: $GTII.C)


2019 Becoming a Big Year for Mergers, Acquisitions and Expansion in #Cannabis; (NYSE: $CGC) (OTC: $SING) (OTC: $HRVSF) (CSE: $GTII.C)


Point Roberts, WA and Delta, BC - March 27, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks continues with our two part series on how the growing cannabis market is boosting ancillary markets, with part two focusing specifically on acquisitions in the cannabis sector.

According to a recent Forbes article, "most of the businesses growing, processing and selling cannabis across the United States are small independently-held entities. That may change in 2019 which looks like a big year for industry mergers, acquisitions and expansion. Large companies, like those in the food, tobacco and pharmaceutical industries have mostly stayed on the sidelines, held back by regulatory concerns, but are now expected to enter the market. The cannabis industry still has a mom and pop feel but that could change rapidly."


Canopy Growth Corp. (NYSE: CGC) (TSX: WEED) is a strong example of one such larger company making acquisitions, having recently acquired AgriNextUSA, a hemp enterprise led by CEO, Geoff Whaling, that has been at the forefront of hemp advocacy and building a vibrant hemp sector in the US. The acquisition is expected to accelerate Canopy Growth's entry into key American jurisdictions as regulations surrounding the full use of hemp as a crop implementation.

SinglePoint (OTC: SING), a company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration in mobile payments, ancillary cannabis services and blockchain solutions, has been very busy making recent acquisitions in Cannabis and most recently solar, all which could benefit their cannabis division was featured in Part One of this series.
The company offers mobile Web checkout gateway services which allow mobile users to purchase goods and services directly from Web-enabled mobile phones through credit or debit cards. It also sells hemp products through SingleSeed.com, supplies hydroponic supplies and nutrients to commercial and individual farmers through retail and online stores. SinglePoint, Inc. was founded in 2007 and is based in Phoenix, Arizona.

Harvest Health and Recreation (OTC: HRVSF) (CSE: HARV) recently announced that it would buy competitor Verano Holdings for $850 million in an all-stock deal, marking the largest US cannabis deal to date. The combined company will be one of the country's largest multi-state operators, presiding over as many as 200 facilities in 16 states.

Steve White, the co-founder and CEO of Harvest, commented on the state of the market in a recent CNBC article. "Presently, we're in a phase that people are referring to it as a land grab," White told CNBC's Fast Money.’ "We plan on ... developing the largest retail footprint, the largest retail platform, in the United States, and with this acquisition, I think we've done that."

Green Thumb Industries Inc. (CSE: GTII) (OTC: GTBIF) also recently announced the closing of the acquisition of For Success Holding Company, the Los Angeles-based creator of the lifestyle suite of Beboe branded cannabis products.

Beboe is the leader in luxury cannabis whose mission is to ‘destigmatize’ legal cannabis through heightened experience and education. Beboe is best known the thoughtful design aesthetic of its iconic rose gold vaporizing pens and edible pastilles, and each product is curated with a unique blend of socially dosed THC and CBD. Beboe is currently available in more than 125 retail locations in California and Colorado and via home delivery across California. In 2018, Beboe launched a direct-to-consumer hemp-derived CBD line of products and introduced several collaborations, including a CBD-infused drink with wellness brand Dirty Lemon.

In early 2019, Barneys New York announced an exclusive partnership with Beboe for a first-of-its-kind luxury cannabis lifestyle and wellness concept shop, “The High End.” The shop will debut at Barneys’ Beverly Hills flagship location in March, with plans to expand to additional locations in the near future. The collaboration includes exclusive, special edition packaging and a silver Beboe vaporizer pen in celebration of the project. With the acquisition by GTI, Beboe products will become available beyond California and Colorado with distribution in select markets.

This “land grab” momentum is expected to continue through 2019 as the cannabis sector expands and consolidates within its own sector and with its ancillary markets. This may mean that the companies making early acquisitions will have a much better chance of success in the market.

Part one The SunnySide of Cannabis; Cannabis Growth Boosts Solar Market; (TSX: $VFF.V) (OTC: $SING) (CSE: $HUGE.C) (CSE: $BGRD.C)

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Follow us on Cannabis Social Media

Investorideas.co Disclaimer :  Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring SING is a paid for news release on Investorideas.com .  Learn more about costs and our  services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com
800-665-0411



How the #Cannabis Industry is Driving #Payment and Data #Tech Solutions: (OTC: $GOHE) (TSXV: $DNAX.V) (TSXV: $RIV.V) (OTC: $REFG)

How the #Cannabis Industry is Driving #Payment and Data #Tech Solutions: (OTC: $GOHE) (TSXV: $DNAX.V) (TSXV: $RIV.V) (OTC: $REFG)


Point Roberts WA, Delta BC – March 27, 2019 - Investorideas.com, a leading investor news resource covering tech and cannabis stocks releases a snapshot looking at how payment technology and data solutions have evolved due to the regulatory hurdles facing the cannabis industry.

PaymentsJournal discussed the “cannabis payments conundrum” and how as the cannabis industry matures we are beginning to see an evolution in payment and data tech companies.

From the article: “The next few years will be hugely important in bringing more validity to the cannabis industry as it continues to expand into new legalized markets. Tapping into the compliant payments solutions will ensure that cannabis dispensaries and retailers will operate above reproach, something their customers/patients, employees, banking partners, and state regulators will appreciate.”

Global Payout Inc. (OTC: GOHE) and its operating subsidiary, MTrac Tech Corp. just announcethat Carol Gabel, a member of the Company’s government relations team at MGR2 has been invited to speak at the New Jersey Cannabis Insider event on April 3rd.

The timing is critical, as next week New Jersey lawmakers are expected to vote on legalization. Gabel will discuss the pending changes in the cannabis payments sector and the company’s flagship product, the MTrac payment platform.

The event brings together many of the key players from throughout the cannabis industry in New Jersey and surrounding tri-state area to provide networking opportunities for both new and established businesses in this rapidly expanding industry.


“Over the course of my career I have had the distinguished opportunity to participate in the legislative process,” said Ms. Gabel. “With this experience I have gained a deep understanding of the legal challenges facing the cannabis industry and have harnessed that experience to help businesses succeed. One of the most challenging aspects of working in the cannabis industry is access to reliable banking and merchant processing services, and I believe MTrac does a lot to solve those problems. MTrac's payment platform helps both businesses and regulatory bodies by providing a secure tracking method for tracing purchases and solves the problems of cash only operations as well.”

The focus of the conference is to help attendees come away with an in-depth understanding of where the law stands, where the law is headed, and how to remain compliant in a complicated regulatory environment.  Ms. Gabel intends to utilize this platform to discuss and highlight MTrac’s unique blockchain-powered cashless payment solution, and how states with legal recreational cannabis are leveraging the technology to increase safety and compliance across the board.





BLOCKSTRAIN TECHNOLOGY CORP. (TSXV: DNAX) (OTC: BKKSF) recently announced that it has entered into a letter of intent with Spark Digital Technologies Inc., whereby the Company will acquire all of the issued and outstanding securities of Spark and the business of Spark.

Spark is the owner of its proprietary platform, IgnitePro™, which was built exclusively for the cannabis industry.  The IgnitePro™ technology is connected globally and will be able to travel with cannabis plants and products as they move from cultivation to distribution. IgnitePro™ will produce reports, store documentation and track transports, and when combined with Blockstrain, is expected to ensure regulation and compliance standards are being met and protected on the blockchain.

Medical Cannabis Payment Solutions Inc. (OTC: REFG), another leading provider of regulatory-compliant financial services for state-sanctioned marijuana, announced back in September the launch of their nationwide banking solution for state-sanctioned cannabis, (PayWithGo) and recently provided an update on its activities in 2018 and its 2019 strategic direction.

Jeremy Roberts, Company CEO commented, “Our corporate mantra has always been compliance, security and accessibility. And we're currently hitting on each of those principles. With the commercialization of Go!, which represents our single most important milestone to-date, we are on the cusp of an entire new era of growth and expansion as cannabis as well as other industries begin to adopt our payment solution."

Canopy Rivers Inc. (TSXV: RIV) has also been keeping a close eye on the rise in cannabis tech having announced earlier in the year that it has completed an equity investment in Headset, Inc., a data and analytics service provider for the cannabis industry. Canopy Rivers subscribed for C$4,084,500 of Series A Preferred Shares in Headset, representing the Company’s first entry into a technology-focused cannabis vertical.

The US House Financial Services Committee is expected to vote on the SAFE Act in the coming weeks, which would permit commercial banks to offer services to cannabis companies that are in compliance with state law. With these developments, the cannabis landscape could change overnight and switch from a cash-based grey system to a transparent economic powerhouse. This will be good news for the many payment and data companies that have already postured to accommodate the cannabis space, and could also represent a massive missed opportunity for the regulated banking sector.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

For investors following payment stocks: visit the tech stocks directory .

About Investorideas.com
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI

Follow us on Cannabis Social Media

Disclaimer/Disclosure:. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring Global Payout nc. (GOHEis a paid for service on Investorideas.com – third party . Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com
800-665-0411

#Biotech Stock News: Positive Results and New Technology Give Rise to Antibody Dominance; (TSXV: $IPA.V) (OTC: $IPATF) (TSX: $ZYME.TO) (NASDAQ: $SESN) (TSX: $PMN.TO)

#Biotech Stock News: Positive Results and New Technology Give Rise to Antibody Dominance; (TSXV: $IPA.V) (OTC: $IPATF) (TSX: $ZYME.TO) (NASDAQ: $SESN) (TSX: $PMN.TO)


Point Roberts, WA, Delta BC - March 27, 2019 - Investorideas.com, a leading investor news resource covering biotech and pharma stocks releases a snapshot looking at the biopharmaceutical market and how monoclonal antibody research is gaining market dominance.

GELifesciences.com, talking about the Antibody boom says; “Many small and start-up companies are developing new ideas as to how antibodies can be used. In many cases, these companies will go on to be acquired by larger companies with the financial capability to progress their ideas further. But with costs to establish manufacturing capability in suitable existing buildings at not much more than $10-15 M, this strategic opportunity lies within reach even for smaller businesses. Despite steep competition and the need for significant investment, the antibody space is a lucrative opportunity with various therapeutic avenues that can be explored.”

Looking at some companies in the sector, Immunoprecise Antibodies Ltd. (TSXV: IPA) (OTC: IPATF), a therapeutic antibody discovery company, recently received a five-year Indefinite Delivery/Indefinite Quantity (ID/IQ) subcontract from Leidos Biomedical Research, Inc., which currently operates the Frederick National Laboratory for Cancer Research for the National Cancer Institute (NCI). Under the subcontract, IPA will discover and produce rabbit monoclonal antibodies using its proprietary B-Cell Select platform.

The rabbit monoclonal antibodies discovered and produced under this subcontract will be used in the key applications of immunohistochemistry and immuno-Multiple Reaction Monitoring (immuno-MRM). The antibodies will be generated for NCI’s Antibody Characterization Program.

Immuno-MRM is a leading-edge targeted mass spectrometry technique that relies on antibodies to enrich peptides from complex biological samples that are then quantified by mass spectrometry. Rabbit monoclonal antibodies are highly sought after for this purpose because they exhibit high specificity and bind their target with high affinity. Immuno-MRM is being used to discover novel biomarkers and develop a new generation of clinical diagnostic tests that could lead to improved cancer detection, diagnosis, and treatment.


Zymeworks Inc. (NYSE: ZYME) (TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics reported in January the achievement of a new development milestone in its collaboration with Eli Lilly and Company. In accordance with Zymeworks’ 2014 licensing and collaboration agreement with Lilly, Zymeworks will receive a milestone payment of US$8.0 million for Lilly’s submission of an IND application for an immuno-oncology bispecific antibody enabled by Zymeworks’ proprietary Azymetric™ platform.
Sesen Bio, Inc. (NASDAQ: SESN), a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of cancer recently reported positive preliminary efficacy data for the primary endpoint of its ongoing Phase 3 registration trial, the VISTA Trial, of Vicinium® for the treatment of patients with high-grade non-muscle invasive bladder cancer (NMIBC) who have been previously treated with bacillus Calmette-Guérin (BCG) and deemed BCG-unresponsive. The data reported show clinically meaningful complete response rates in evaluable Carcinoma in situ patients at three, six, nine and twelve months of follow-up in the trial consistent with the data in the completed Phase 1 and Phase 2 clinical trials. Importantly, Vicinium continues to be generally well-tolerated in treated patients.

ProMIS Neurosciences, Inc. (TSX: PMN) (OTC: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases will soon present data for new antibody candidates that show stringent selectivity for the toxic forms of alpha-synuclein, considered a root cause of Parkinson's disease.  ProMIS Neurosciences' Chief Scientific Officer, Dr. Neil Cashman will discuss the preclinical data at a podium presentation on March 31 as well as co-moderate the March 30 panel discussion on disease mechanisms in Alzheimer's disease and Parkinson's disease.

ResearchandMarkets, in a biopharma market overview reported, “The global biopharmaceuticals market was valued at USD 237,250.8 million in 2018, and is estimated to be valued at USD 388,997.3 million in 2024, witnessing a CAGR of 8.59%.”

Within the related segments, Monoclonal Antibodies are expected to gain the largest market size.

For investors following medical technology and healthcare stocks, Investor Ideas has created a directory of biotech and medical technology stocks

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI

Follow us on Social Media
Follow us on Twitter https://twitter.com/Investorideas


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring  (TSX VENTURE: IPA) (OTC PINK: IPATF)  a paid for service on Investorideas.com(third party)  . Learn more about costs and our  services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com
800-665-0411

Tuesday, March 26, 2019

Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Fire & Flower (TSXV: $FAF.V), Cannara Biotech (CSE: $LOVE.C), Cannabis Growth Opportunity (CSE: $CGOC.C), Vireo Health (CSE: $VREO.C) and SOL Global (CSE: $SOL.C)



Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Fire & Flower (TSXV: $FAF.V), Cannara Biotech (CSE: $LOVE.C), Cannabis Growth Opportunity (CSE: $CGOC.C), Vireo Health (CSE: $VREO.C) and SOL Global (CSE: $SOL.C)



Delta, Kelowna, BC –March 26, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we are looking at announcements from Fire & Flower Holdings Corp. (TSXV: FAF), Cannara Biotech Inc. (CSE: LOVE), Cannabis Growth Opportunity Corporation (CSE: CGOC), Vireo Health (CSE:VREO) and SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF).

Fire & Flower Holdings Corp. today announced successful first month operations of its cannabis Click & Collect service.

The Click & Collect service allows age-verified adult-use cannabis consumers to reserve cannabis and accessory products for pickup at stores across the provinces of Alberta and Saskatchewan. The service was launched as part of the Company's mission to curate the world of cannabis for its customers who seek a more convenient and informative buying experience. Certain cannabis products sell out rapidly, and the Click & Collect service ensures customers are able to reserve high-demand products and receive priority service when visiting a store.

"The Click & Collect service has been adopted very favourably, particularly by our loyal customers using mobile devices," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "We are seeing rapid and continuous growth in use of our Click & Collect service across the entire Fire & Flower retail network."

The service was developed by HiFyre Inc., Fire & Flower's digital product studio that was acquired by the Company in July of 2018. HiFyre Inc. has significant cannabis e-commerce experience including work for Mettrum Health Corp., Starseed Medicinal Inc. and Canopy Growth Corporation.

Cannara Biotech Inc., an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its subsidiary Global shopCBD.com Inc. ("shopCBD.com") has closed private rounds of financing for aggregate proceeds of $8,865,849.15.  Cannara remains the majority shareholder of the U.S. based online e-commerce platform with an approximately 61% ownership position.

"As the hemp CBD consumer markets continue to evolve, what is increasingly clear is the health and wellness segment is becoming more prominent," said Zohar Krivorot, President and CEO of Global shopCBD.com. "The high level of investor interest in participating in shopCBD.com underscores the potential of both CBD products overall and moreover, a best-in-class online platform to serve this market." 

Cannabis Growth Opportunity Corporation, a cannabis focused investment corporation with both public and private cannabis holdings, reported that Vireo Health International Inc., one of the private portfolio holdings commenced trading on the Canadian Securities Exchange , under the symbol "VREO", on March 20, 2019, at an opening price of $5.65. In conjunction with its previously announced business combination with Darien Business Development Corp, Vireo raised over US$50 million by way of brokered and non-brokered private placement offerings.

Vireo is a physician-founded and scientifically-focused multi-state medical cannabis company. CEO Dr. Kyle Kingsley founded the Company in 2014 after winning one of only two vertical licenses issued by the state of Minnesota. The Company has gone on to expand its business across multiple states, focusing its efforts on limited license medical states.  Vireo has a successful track record of winning licenses in competitive application processes.

Jamie Blundell, President and Chief Operating Officer of CGOC commented"Vireo has proven to be a committed and dedicated company, who have achieved their goals and objectives as stated. We expect significant upside within the company as they continue to expand their reach across the US.
"Our investment in Vireo has provided a return of 188% in nine months and is a great example of how our private investments can quickly add value to CGOC. This will positively impact our NAV when calculated in April. At the current share price, CGOC represents a unique and vastly discounted opportunity to benefit from the continued success within this sector."

SOL Global Investments Corp. announced its investment in leading premium soda-maker Jones Soda Co. (OTCQB: JSDA).

SOL Global has acquired 3,396,049 common shares of Jones Soda in the open market. SOL Global's total investment represents approximately 8.19% of the total issued and outstanding common shares of Jones Soda which, based on publicly available information, makes it the company's largest stockholder. SOL Global has filed a Schedule 13D with the United States Securities and Exchange Commission describing its investment in Jones Soda.

The Seattle-based Jones Soda Co., founded in 1986, is known for its wide variety of flavored craft sodas, made with pure cane sugar and other high-quality ingredients. The company's most recent product launch, Jones Ginger Beer - as well as two new sugar-free soda flavors - join its core brands including its Jones Soda product line, Jones Carbonated Candy, and Lemoncocco, a premium non-carbonated drink made with high-quality lemon and coconut flavors. Jones Soda is sold in eye-catching glass bottles and cans and in fountains at restaurants and is distributed throughout North America. The company continues to innovate its core brands as demand for healthier sodas that contain high-quality ingredients grows and has also redeveloped the majority of its product line using colors derived from natural sources.

"Jones Soda has an iconic, retro brand in the Soda Bottle and Fountain Beverage sector, and we believe the company's true value will be recognized by the market as its new offerings gain steam," said SOL Global Chief Investment Officer Andy DeFrancesco. "It is clear that Jones Soda is committed to being on the front lines of innovative product development, while staying true to their iconic brand."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708


Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move.  Learn more https://www.investorideas.com/membership/






About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication  services and costs https://www.investorideas.com/News-Upload/ 
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411